Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 The Services Sector as India’s Growth Multiplier: Challenges and Policy Pathways
- 2 India’s Clean Energy Leap: Opportunities, Obstacles & the Road to 2030
- 3 Decoding India’s Strategic Reset with Afghanistan
- 4 India, Mongolia Mark 70 Years of Diplomatic Ties
- 5 AI Roadmap for Inclusive Societal Development
- 6 India-Russia Relations: Celebrating Decades of Unwavering Trust
- 7 RTI at 20: Milestones, Challenges and the Road Ahead
- 8 India’s Biotech Surge: Powering Growth Through Science
- 9 Kautilya Economic Conclave 2025: Navigating India’s Path in a Fragmented Global Economy
- 10 Abolition of GST Compensation Cess: Concerns Over States’ Revenue & Fiscal Autonomy
